Add to Favorites Newsroom RSS Share
Durham, NC USA

Our News on Newswise

Tcell_FECCI_edit1.jpg

Duke Team Finds Missing Immune Cells That Could Fight Lethal Brain Tumors

Researchers at Duke Cancer Institute have tracked the missing T-cells in glioblastoma patients. They found them in abundance in the bone marrow, locked away and unable to function because of a process the brain stimulates in response to...
13-Aug-2018 10:05 AM EDT Add to Favorites

MGD-final.jpg

Immune Response Likely Culprit in Eyelid Gland Condition That Causes Dry Eye

Immune cells that normally rush in to protect the eyes from infection might actually be disrupting moisturizing glands and causing dry eye, a disease that afflicts more than 30 million people in the United States.
22-Jul-2018 7:30 PM EDT Add to Favorites

ALLgraphic_SIPKINS_edit2.jpg

Researchers Solve Mystery of How ALL Enters the Central Nervous System

A research team led by Duke Cancer Institute scientists has found that this blood cancer infiltrates the central nervous system not by breaching the blood-brain barrier, but by evading the barrier altogether.
18-Jul-2018 1:00 PM EDT Add to Favorites

Duke.Health.Friedman.Surgeryjpg.jpg

Poliovirus Therapy for Recurrent Glioblastoma Has 3-Year Survival Rate of 21%

A genetically modified poliovirus therapy developed at Duke Cancer Institute shows significantly improved long-term survival for patients with recurrent glioblastoma, with a three-year survival rate of 21 percent in a phase 1 clinical trial.
26-Jun-2018 2:40 PM EDT Add to Favorites

Analysis: Survival Benefit for African-Americans with Advanced Prostate Cancer

Contrary to current perceptions, certain African-American men with advanced prostate cancer have as good a chance of survival as white men and might actually have a small advantage, according to a new analysis of more than 8,000 patients who...
1-Jun-2018 2:00 PM EDT Add to Favorites

Black Patients Show Stronger Response to Hormone Therapy for Prostate Cancer

African-American men with advanced prostate cancer might be more responsive than white men to an anti-androgen drug and steroids, according to a study led by Duke Cancer Institute researchers.
1-Jun-2018 2:00 PM EDT Add to Favorites

Bone Scan Software Accurately Calculates Prognosis of Advanced Prostate Cancer

A software tool to automatically calculate how extensively bones have been infiltrated by prostate cancer is both accurate and speedy, capturing key prognostic information related to survival and the development of symptoms over time.
15-May-2018 4:35 PM EDT Add to Favorites

Deadly Cancers Show Early, Detectable Differences From Benign Tumors

Do metastatic cancer tumors "break bad" or are they "born bad"? In a study publishing the week of May 14 scientists found that in the colorectal tumors they examined, invasive cancers are born to be bad, and this tendency can potentially be...
9-May-2018 2:45 PM EDT Add to Favorites


see all news

Our YouTube Videos





Chat now!